# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target f...
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...
Testing offers CBR families the opportunity to proactively seek additional information about their child's health
UBS analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Neutral rating and announces Price Targe...
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per ...